Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02825706
Other study ID # EducationalPhys
Secondary ID
Status Completed
Phase N/A
First received June 30, 2016
Last updated July 6, 2016
Start date February 2012
Est. completion date April 2015

Study information

Verified date July 2016
Source Real Fundación Victoria Eugenia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Although arthropathy is a serious problem in patients with hemophilia due to the associated morbidity and incapacity, to the best of the investigators knowledge, no studies have looked at the effect of educational physiotherapy for its clinical improvement.

This contribution presents the results of educational physiotherapy program applied for 15 weeks with home exercises - in patients with hemophilic arthropathy. After treatment, experimental group showed improved a significant reduction of pain, and best quality of life al illness behaviour. During treatment no patient showed elbow haemarthrosis, which underlines the safety of this physiotherapy program.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date April 2015
Est. primary completion date October 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients diagnosed with hemophilia A or B

- Patients over 18 years

- Patients with hemophilic arthropathy with at least 1 involved joint (elbow, knee or ankle)

- having signed the informed consent document.

Exclusion Criteria:

- Patients diagnosed with other congenital bleeding disorders (i.e. von Willebrand disease)

- Patients who developed antibodies to FVIII or FIX (inhibitors)

- Those not able to ambulate as a result of hemophilic arthropathy or any other disability

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Educational physiotherapy group
20 patients with hemophilia were randomly allocated to an educational intervention or to a control group. The educational intervention was performed every two weeks during 15-week and home exercises were performed once a day, 6 days a week, in the same time

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Real Fundación Victoria Eugenia

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline physical condition of joints after treatment and at 6 months The physical condition of joints was assessed using the Gilbert scale that measures swelling, muscle atrophy, joint crepitus, range of motion, axial deformity and instability. Scores range from 0 to 12 (0 represents no joint injury and 12 represents maximum joint deterioration). Screening visit, within the first seven days after treatment and after six months follow-up visit
Primary Change from baseline joint pain after treatment and at 6 months Joint pain was assessed using the Visual Analog Scale (VAS), with scores ranging from 0 (no pain at all) to 10 (the worst pain imaginable by the patient). Screening visit, within the first seven days after treatment and after six months follow-up visit
Primary Change from baseline perception of the quality of life after treatment and at 6 months The Haemophilia A-36 questionnaire was used to assess the perception of the quality of life. This questionnaire consists of 36 items that assess 9 domains (physical health, daily activities, joint damage and pain, treatment satisfaction, treatment difficulties, emotional functioning, mental health and social relationships). Screening visit, within the first seven days after treatment and after six months follow-up visit
Primary Change from baseline illness behavior after treatment and at 6 months To assess illness behavior, patients completed the Illness Behavior Questionnaire (IBQ). This scale consists of 62 items and 8 domains (hypochondriasis, disease conviction, psychological vs. somatic perception of illness, affective inhibition, affective disturbance, denial and irritability). Screening visit, within the first seven days after treatment and after six months follow-up visit
Primary Change from baseline frequency of bleedings after treatment and at 6 months The frequency of bleeding is measured with a record which complete the patients, where they indicate the incidence of hematomas and hemarthrosis during the treatment and follow-up. Screening visit, within the first seven days after treatment and after six months follow-up visit
Secondary Radiological joint deterioration All patients had an assessment of radiological joint deterioration using the Pettersson scale. This scale, with scores ranging from 0 (a normal joint) to 13 (maximum joint deterioration), is the most widely used to assess joint degeneration produced by hemophilic arthropathy. The evaluation of radiological joint damage was done at the beginning of the study. Screening visit
Secondary Age Age of patients included in the study Screening visit
Secondary Weight Weight of the patients Screening visit
Secondary Height Height of patients Screening visit
See also
  Status Clinical Trial Phase
Completed NCT02229331 - Biomechanical Determinants and Patterns Associated to the Pathophysiological Cascade of Ankle Arthropathy in Children With Haemophilia: Non-invasive In-vivo Measurement of Foot Joints in Children With Haemophilia During Gait.
Completed NCT02870114 - National Survey of People With Haemophilia in Portugal N/A
Recruiting NCT02197611 - Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia. N/A
Unknown status NCT02582450 - Validation of a Specific Measure for Assessment of Compliance With Treatment in Patients With Hemophilia N/A
Completed NCT05138224 - Prevalence of Autistic Spectrum Disorder (ASD) in Children With Haemophilia
Recruiting NCT03287999 - Inter Individual Variability in Initiation Pathway Activation and Regulation and Phenotypic Heterogeneity in Patients With Haemophilia A and B
Completed NCT02825667 - Effectiveness of the Myofascial Therapy in the Hemophilic Arthropathy of Ankle N/A
Completed NCT03818529 - ATHN 8: Previously Untreated Patients (PUPs) Matter Study
Completed NCT05108480 - Self-myofascial Release With Foam Roller in Patients With Hemophilic Knee Arthropathy N/A
Completed NCT02781233 - A Progressive Resistance Training Program in Patients With Haemophilia N/A
Active, not recruiting NCT02581735 - Effectiveness of the uPatient Platform in Prophylactic Treatment in Hemophilia N/A
Active, not recruiting NCT02512211 - Validation of Questionnaires HAL and HEP N/A
Not yet recruiting NCT01623960 - Quality of Life in Adult Patients With Severe Haemophilia in Turkey N/A
Recruiting NCT02191436 - Adherence to Treatment in Hemophilia N/A
Completed NCT03264014 - Combining Registry Data in Haemophilia: TARGET H N/A
Recruiting NCT02198430 - Multidisciplinary Evaluation of Patients With Hemophilia N/A
Not yet recruiting NCT06046235 - Virtual Evaluations of Joint Health Using Wearable Sensors in Persons With Haemophilia (VESPA)
Completed NCT03529474 - Psychology and Physiotherapy Approach of Chronic Pain in Patients With Hemophilia N/A
Completed NCT05425888 - Functional and Proprioceptive Status in Patients With Hemophilic Ankle Arthropathy
Recruiting NCT03914209 - Extended Half-Life (EHL) Clotting Factor for Improving the Musculoskeletal Health of Patients With Hemophilia